Urinalysis Market To Hit Value .4 Billion By 2030 |Grand View Research, Inc.

Posted by Mrudula Anil Karmarkar on March 2nd, 2023

The global urinalysis market size is expected to reach USD 5.4 billion by 2030, according to a new study by Grand View Research Inc. The market is expected to witness a CAGR of 4.6% from 2022 to 2030. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms referable to the Gastrointestinal Tract (GU).

Increasing geriatric population and the subsequent increase in age related diseases in developed and developing regions will positively influence urinalysis market growth. According to the World Health Organization (WHO), the geriatric population increased from 1 billion in 2020 to 1.4 billion in 2021. The early diagnosis and management of chronic diseases in geriatric population is responsible for the increasing prescription rate for tests such as bilirubin, ketones, glucose, and creatinine. These tests are performed by urinalysis; hence, it is anticipated to drive market growth.

Moreover, for patients undergoing transplant surgeries including kidney and liver, transplant procedures is often recommended to undergo preoperative urinalysis to avoid urinary tract infections (UTIs). According to United Network for Organ Sharing data, around 24,669 kidney transplants, 9,236 liver transplants, and 3,817 heart transplants were performed in the U.S. in 2021. Thus, an increasing number of transplant surgeries is expected to fuel market growth.

Companies are taking initiatives such as collaboration and strategic partnerships for the development and marketing of technologically advanced urinalysis products. For instance, in October 2021, Sysmex entered into collaboration with Inpeco for the development of an automated urinalysis workflow solution of the highest level. This product was developed with a help of UN-Series of Sysmex's and FlexLab TM track of Inpeco’s urinalysis solutions. It is the only fully open automation system that helps laboratories optimize their workflow support and provide premium patient care.

Urinalysis market is witnessing growth due to the factors such as the rising incidence of diseases such as Urinary Tract Infections (UTIs), diabetes, and kidney diseases. The rising usage of automated and advanced According to National Diabetes Statistics Report, 2020, around 34.2 million population aged 18 years and above had diabetes in the U.S. About one-third of diabetes people have kidney-related comorbidities due to high blood sugar and blood pressure. Urinalysis is an informative and noninvasive diagnostic tool that is accessible to clinicians to diagnose kidney disease. Hence, the rising prevalence of kidney diseases is anticipated to increase demand for products that are used in urinalysis, thereby, driving the market growth.

To Request Sample Copy of this report, click the link:

https://www.grandviewresearch.com/industry-analysis/urinalysis-market/request/rs1

During the initial phase of the COVID -19 pandemic, the market for urinalysis was moderately impacted due to the low hospitalization rate and declining sales of urine analysis tests. Nationwide lockdowns imposed by governments to control the spread of infection restricted people’s access to diagnostic and hospital services leading to low demand for diagnostics products. However, a resurgence in testing numbers is seen as countries eased restrictions on movement. The growing importance of urinalysis for detecting post-COVID-19 diseases such as acute kidney & tubular injuries is anticipated to drive market growth. According to the Columbia University study (2021), kidney injury marker-1 (KIM-1) and urinary NGAL were two sensitive biomarkers for detecting tubular and kidney injury patients.

Developing countries such as South Korea, Brazil, India, and Mexico are expected to offer potential growth opportunities for key players in the urinalysis market. This can be attributed to the increasing burden of chronic diseases, improved healthcare infrastructure, a large patient base, and increased disposable income. For instance, the healthcare expenditure in India increased from USD 232.73 million in 2020 to USD 507.97 million in 2021.

Urinalysis Market Report Highlights

• Based on product, the consumables segment held the largest share market in 2021 due to wider usage of dipsticks due to their efficiency coupled with lost costs
• Based on application, the disease screening segment accounted for the largest segment, owing to the increasing prevalence of target diseases such as UTI, kidney disease, and liver disease, along with the rising application of urinalysis for screening of these diseases
• On the basis of end-use, the clinical laboratories segment dominated the market in 2021 owing to higher patient footfall in clinical laboratories for urine testing for disease diagnosis
• Home care segment is expected to witness significant growth over the forecast period owing to increasing investment for the development of home-based urine testing kits for disease diagnosis
• North America segment dominated the market in 2021 due to favorable reimbursement policies, rising incidence of UTI, well-established healthcare infrastructure, and supportive regulatory reforms

Furthermore, screening programs are undertaken by governments for the early detection of diseases such as urinary and renal disorders. For instance, around 12,497 students of primary and secondary schools from Pingyang, Cangnan, and Yongjia in Wenzhou, China were screened for urinalysis under school urinary analysis programs. The urine abnormalities were seen in primary school students with a detection rate of 36% and 95% in secondary school students. The rising number of such programs is expected to drive the demand for urinalysis tests.

Increased investment in the development of home-based urine testing kits for disease diagnosis contributes to segment growth. For instance, in November 2021, Vivoo raised funding of USD 6 million for the development of at-home urine tests to provide lifestyle and nutrition guidance. In developing countries, which are price sensitive, preferred inexpensive cost and equally functional analyzers for routine urinalysis tests. Hence, developing low-cost urinalysis tests is expected to fuel market growth.

List of Key Players of Urinalysis Market

• Abbott
• Sysmex Corporation
• Siemens Healthcare GmbH
• ACON Laboratories, Inc.
• ARKRAY Inc.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• F. Hoffmann-La Roche Ltd.
• Quidel Corporation
• Bio-Rad Laboratories, Inc.